FULC’s $150 Million Public Offering Targets R&D and Growth—Will Expanded Funding Accelerate Innovation?
Market Chameleon (Tue, 9-Dec 8:39 AM)
Inducement Stock Options Grant Highlights Fulcrum Therapeutics’ Talent Strategy as Shares Surge
Market Chameleon (Mon, 8-Dec 9:54 AM)
